Top Venous Stents Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Venous Stents Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Venous Stents industry players.

Venous Stents Market Competitive Landscape

The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation.

  • Oxford Endovascular (2015, UK): Oxford Endovascular, a University of Oxford spin-out, is developing stent technology based on origami to treat brain aneurysms. The nickel-titanium alloy stents are potentially foldable into less invasive packages and could be delivered through microcatheters. When deployed to repair dilated blood arteries, they expand. The technology beneath has the potential to be applied to venous procedures as well, providing new solutions for complex vascular issues, although their current focus is on neurovascular applications.
  • Oxford Heartbeat (2015, UK): Oxford Heartbeat has created advanced software that creates 3D models of a patient's cerebral blood arteries using 2D medical imaging. This increases stent placement accuracy and reduces the risk of complications by allowing surgeons to model and select the best stent for each case. This method was initially used on cerebral arteries, but it could possibly be used for venous systems as well and enhance the effects of venous stenting treatment through personalized planning.

Top Player’s Company Profiles

  • Boston Scientific Corporation
  • Medtronic Plc
  • Becton, Dickinson and Company
  • Cook Medical
  • Gore Medical
  • Abbott Laboratories
  • Vesper Medical
  • Optimed Medizinische Instrumente GmbH
  • BIOTRONIK SE & Co. KG
  • Bentley InnoMed GmbH
  • Cordis Corporation
  • Plus medica GmbH & Co.
  • Philips Healthcare
  • Stryker Corporation

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Venous Stents Market size was valued at USD 2.04 Billion in 2023 and is poised to grow from USD 2.13 Billion in 2024 to USD 3.06 Billion by 2032, growing at a CAGR of 4.62% in the forecast period (2025-2032).

The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation. 'Boston Scientific Corporation', 'Medtronic Plc', 'Becton, Dickinson and Company', 'Cook Medical', 'Gore Medical', 'Abbott Laboratories', 'Vesper Medical', 'Optimed Medizinische Instrumente GmbH', 'BIOTRONIK SE & Co. KG', 'Bentley InnoMed GmbH', 'Cordis Corporation', 'Plus medica GmbH & Co.', 'Philips Healthcare', 'Stryker Corporation'

Increase in chronic venous conditions like post-thrombotic syndrome and deep vein thrombosis globally is one of the key factors driving the growth of the venous stents market. Intervention therapy can be a requirement for the treatment of specific conditions to rejuvenate blood supply and alleviate the long-term impacts. Demand for venous stents is increasing in mature and emerging healthcare markets because of better diagnosis rates and greater awareness among aging populations, which is propelling the industry's steady growth.

Transition to Less Invasive Procedures: With shorter recovery periods, fewer risks of operation, and greater patient satisfaction, there is a global trend towards less invasive venous treatments. Venous stents play a key role in these methods, especially for venous diseases like iliofemoral vein obstruction. Demand for stents compatible with less invasive techniques is increasing as healthcare economics increasingly focus on outpatient and day surgery programs. This affects hospital buying habits and product design.

Why Does North America Dominate the Venous Stents Market?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Venous Stents Market
Venous Stents Market

Report ID: SQMIG35A3037

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE